MODIFICATION TO LUCAS
Device Facts
| Record ID | K062401 |
|---|---|
| Device Name | MODIFICATION TO LUCAS |
| Applicant | Jolife AB |
| Product Code | DRM · Cardiovascular |
| Decision Date | Sep 28, 2006 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 870.5200 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
LUCAS® External Cardiac Compressor is to be used for performing external cardiac compressions on adult patients who have acute circulatory arrest defined as absence of spontaneous breathing and pulse, and loss of consciousness. LUCAS® must only be used in cases where manual chest compression would be used. LUCAS® is only intended for temporary use.
Device Story
LUCAS® is a pneumatically powered mechanical chest compression system for adult patients in acute circulatory arrest. The device consists of an upper unit with a piston rod and a back plate. A pressure pad integrated into a suction cup acts on the patient's chest to provide automated, consistent, and uninterrupted compressions. Powered by compressed air from wall outlets or cylinders, the device is applied to the patient in under 20 seconds. It allows for hands-free operation and enables emergency personnel to remain safely belted during patient transport. By providing consistent compressions according to AHA guidelines, the device aims to maintain circulation during transport and resuscitation efforts. Healthcare providers use the device to replace manual compressions, potentially improving the quality and consistency of CPR while ensuring provider safety.
Clinical Evidence
No clinical data provided. Substantial equivalence is supported by functional bench testing conducted under various operating conditions to verify compliance with product specifications.
Technological Characteristics
Pneumatically powered mechanical chest compressor. Features a piston-driven compression pad integrated with a suction cup for active decompression (limited to 3lbs). System includes an upper unit and back plate. Operates via compressed air (hospital wall outlet or cylinder).
Indications for Use
Indicated for adult patients experiencing acute circulatory arrest (absence of spontaneous breathing, pulse, and consciousness) requiring external cardiac compression. Intended for temporary use in scenarios where manual chest compression is indicated.
Regulatory Classification
Identification
An external cardiac compressor is an externally applied prescription device that is electrically, pneumatically, or manually powered and is used to compress the chest periodically in the region of the heart to provide blood flow during cardiac arrest. External cardiac compressor devices are used as an adjunct to manual cardiopulmonary resuscitation (CPR) when effective manual CPR is not possible (e.g., during patient transport or extended CPR when fatigue may prohibit the delivery of effective/consistent compressions to the victim, or when insufficient EMS personnel are available to provide effective CPR).
Special Controls
*Classification.* Class II (special controls). The special controls for this device are:(1) Nonclinical performance testing under simulated physiological conditions must demonstrate the reliability of the delivery of specific compression depth and rate over the intended duration of use. (2) Labeling must include the following: (i) The clinical training necessary for the safe use of this device; (ii) Adjunctive use only indication prominently displayed on labels physically placed on the device and in any device manuals or other labeling; (iii) Information on the patient population for which the device has been demonstrated to be effective (including patient size and/or age limitations, *e.g.,* adult, pediatric and/or infant); and(iv) Information on the time necessary to deploy the device as demonstrated in the performance testing. (3) For devices that incorporate electrical components, appropriate analysis and testing must demonstrate that the device is electrically safe and electromagnetically compatible in its intended use environment. (4) Human factors testing and analysis must validate that the device design and labeling are sufficient for effective use by the intended user, including an evaluation for the time necessary to deploy the device. (5) For devices containing software, software verification, validation, and hazard analysis must be performed. (6) Components of the device that come into human contact must be demonstrated to be biocompatible.
Predicate Devices
Reference Devices
- Autopulse model 100 (K040453)